Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Dahlmann, Mathias Dr. (29) Daniel, Peter Prof. Dr. (3) Fritsche, Raphaela Dr. (2) Haas, Simon Dr. rer. nat. (1) Hartl, Kimberly (1) Herse, Florian PD Dr. (1) Holz, Maximilian (1) Horne, Arik (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (1) Keller, Ulrich Dr. med. (2) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Malchin, Victoria (1) Mertins, Philipp Dr. (4) Na, Il-Kang Dr. (1) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Özerdem, Ceren (1) Pezzutto, Antonio Prof. Dr. (4) Pischon, Tobias Prof. Dr. (1) Popp, Oliver Dr. (3) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Röefzaad, Claudia (1) Schlag, Peter M. Prof. Dr. (378) Schmitt, Clemens Prof. Dr. (2) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Solé Boldo, Llorenc Dr. rer. nat. (1) Specker, Edgar Dr. (2) Sperling, Silke Prof. Dr. (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (187) Torke, Sebastian Dr. (4) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (1) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (145) Wenzel, Katrin Dr. (1) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Zimmermann, Karin Dr. (1) (-) Smith, Janice (16) 2006 (1) 2008 (1) 2009 (2) 2011 (1) 2012 (1) 2013 (1) 2014 (1) 2016 (1) 2017 (2) 2020 (1) 2021 (1) 2022 (1) 2023 (2) Developmental Neurobiology (1) Mathematical Modelling of Cellular Processes (1) Proteomics (2) (-) Translational Oncology of Solid Tumors (16) 16 Results: Active Filter: Smith, JaniceTranslational Oncology of Solid Tumors Sort: Result score Newest to oldest Oldest to newest May 30, 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein November 01, 2006 / Gastroenterology The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor (TCF) signaling in colon cancer U. Stein F. Arlt W. Walther J. Smith T. Waldman E.D. Harris S.D. Mertins C.W. Heizmann D. Allard W. Birchmeier P.M. Schlag R.H. Shoemaker August 01, 2009 / Cell Cycle MACC1 controls Met: What a difference an Sp1 site makes U. Stein J. Smith W. Walther F. Arlt January 01, 2009 / Nat Med MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis U. Stein W. Walther F. Arlt H. Schwabe J. Smith I. Fichtner W. Birchmeier P.M. Schlag August 01, 2012 / Clin Exp Metastasis In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice A. Pichorner U. Sack D. Kobelt I. Kelch F. Arlt J. Smith W. Walther P.M. Schlag U. Stein February 01, 2011 / Neoplasia Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis U. Stein F. Arlt J. Smith U. Sack P. Herrmann W. Walther M. Lemm I. Fichtner R.H. Shoemaker P.M. Schlag August 26, 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein November 17, 2016 / Oncogene SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival F. Schmid Q. Wang M.R. Huska M.A. Andrade-Navarro M. Lemm I. Fichtner M. Dahlmann D. Kobelt W. Walther J. Smith P.M. Schlag U. Stein August 01, 2017 / Ann Oncol Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies U.P. Rohr P. Herrmann K. Ilm H. Zhang S. Lohmann A. Reiser A. Muranyi J. Smith S. Burock M. Osterland K. Leith S. Singh P. Brunhoeber R. Bowermaster J. Tie M. Christie H.L. Wong P. Waring K. Shanmugam P. Gibbs U. Stein December 01, 2013 / Neuro Oncol Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis C. Hagemann S. Fuchs C.M. Monoranu P. Herrmann J. Smith T. Hohmann U. Grabiec A.F. Kessler F. Dehghani M. Loehr R.I. Ernestus G.H. Vince U. Stein Pagination Current page 1 Page 2 Next page Next › Last page Last »
May 30, 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein
November 01, 2006 / Gastroenterology The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor (TCF) signaling in colon cancer U. Stein F. Arlt W. Walther J. Smith T. Waldman E.D. Harris S.D. Mertins C.W. Heizmann D. Allard W. Birchmeier P.M. Schlag R.H. Shoemaker
August 01, 2009 / Cell Cycle MACC1 controls Met: What a difference an Sp1 site makes U. Stein J. Smith W. Walther F. Arlt
January 01, 2009 / Nat Med MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis U. Stein W. Walther F. Arlt H. Schwabe J. Smith I. Fichtner W. Birchmeier P.M. Schlag
August 01, 2012 / Clin Exp Metastasis In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice A. Pichorner U. Sack D. Kobelt I. Kelch F. Arlt J. Smith W. Walther P.M. Schlag U. Stein
February 01, 2011 / Neoplasia Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis U. Stein F. Arlt J. Smith U. Sack P. Herrmann W. Walther M. Lemm I. Fichtner R.H. Shoemaker P.M. Schlag
August 26, 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein
November 17, 2016 / Oncogene SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival F. Schmid Q. Wang M.R. Huska M.A. Andrade-Navarro M. Lemm I. Fichtner M. Dahlmann D. Kobelt W. Walther J. Smith P.M. Schlag U. Stein
August 01, 2017 / Ann Oncol Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies U.P. Rohr P. Herrmann K. Ilm H. Zhang S. Lohmann A. Reiser A. Muranyi J. Smith S. Burock M. Osterland K. Leith S. Singh P. Brunhoeber R. Bowermaster J. Tie M. Christie H.L. Wong P. Waring K. Shanmugam P. Gibbs U. Stein
December 01, 2013 / Neuro Oncol Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis C. Hagemann S. Fuchs C.M. Monoranu P. Herrmann J. Smith T. Hohmann U. Grabiec A.F. Kessler F. Dehghani M. Loehr R.I. Ernestus G.H. Vince U. Stein